Hormel Foods Q3 EPS Misses on Charges, But Raises Adjusted FY26 Outlook
HRL sits 22% above its 52-week low of $19.7.
Summary
Hormel Foods reported Q3 FY2026 adjusted EPS of $0.37, beating last year's $0.35, but GAAP EPS fell to $0.11 on divestiture, impairment, and litigation charges. The company raised its full-year adjusted EPS guidance to $1.45-$1.51.
Key Events · Earnings and Guidance · HRL
-
Q3 Adjusted EPS Beats, GAAP EPS Misses
Adjusted diluted EPS of $0.37 vs $0.35 a year ago; GAAP diluted EPS of $0.11 vs $0.33, reflecting $56M Brazil divestiture loss, $48M Indonesia impairment, and $38M litigation settlement.
-
FY26 Adjusted EPS Guidance Raised
Adjusted diluted EPS outlook raised and narrowed to $1.45-$1.51 (6%-10% growth), up from prior $1.43-$1.51; GAAP EPS outlook lowered to $1.06-$1.12 from $1.28-$1.37.
-
Net Sales Guidance Trimmed
FY2026 net sales outlook lowered to $12.1B-$12.2B from $12.2B-$12.5B; organic net sales growth now expected at 1%-2% vs prior 1%-4%.
-
Brazil Divestiture Closed
Sale of Brazil operations (Ceratti brand) closed in early Q4 FY2026; Q3 included a $56M loss on the divestiture, and the business is classified as held for sale.
Analysis · HRL · Manufacturing
Hormel Foods reported Q3 GAAP diluted EPS of $0.11, down sharply from $0.33 a year ago, driven by a $56M Brazil divestiture loss, a $48M non-cash impairment on an Indonesian minority investment, and a $38M antitrust litigation settlement. Adjusted EPS of $0.37 beat the prior-year $0.35. Management raised and narrowed its full-year adjusted EPS guidance to $1.45-$1.51, reflecting confidence in underlying operations despite portfolio-shaping charges. The company also lowered its GAAP EPS outlook to $1.06-$1.12 and trimmed net sales guidance to $12.1B-$12.2B. The Brazil divestiture closed in early Q4, simplifying the international portfolio.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HRL was trading at $23.99 on NYSE in the Manufacturing sector, with a market capitalization of approximately $13.1B. The 52-week trading range was $19.70 to $29.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.